Giving low-income adults incentives to buy fresh fruit and vegetables at local farmers markets may help reduce obesity and disease, U.S. researchers say. Suzanne Lindsay, executive director of the Institute for Public Health San Diego ...
Tags: demand, priduce, household, low-income
Alnylam Pharmaceuticals, a RNAi therapeutics company, announced that the US Food and Drug Administration (FDA) has granted fast track designation to patisiran (ALN-TTR02) for the treatment of transthyretin (TTR)-familial amyloid ...
Tags: Alnylam, Fast Track Designation
About 106,000 Americans picked health plans in the 30 days of the new enrollment period, with almost a million more in the works, an official said Wednesday. U.S. Health and Human Services Secretary Kathleen Sebelius said for the first ...
Tags: health insurance, USA, plan, work, shopping
US-based CEL-SCI has obtained an approval from the Health Protection Administration, Ministry of Health, of the Croatian Republic to begin patient enrollment in Phase III clinical trial of its investigational cancer immunotherapy treatment, ...
Austria-based Miracor Medical Systems has announced that 30 patients have been successfully treated with no device-related adverse events using its PICSO (pressure-controlled intermittent coronary sinus occlusion) system designed to improve ...
Tags: PICSO System, Medical Systems
Almost 80 percent of U.S. Medicare beneficiaries age 65 and older don't know the last day for open enrollment to make changes in their insurance plan is Dec. 7. Medicare beneficiaries have from Oct. 15 to Dec. 7 to make changes in their ...
Tags: medicare, beneficiaries, last day, insurance
Germany-based medical technology company MagForce has installed a NanoActivator at the University Hospital Munster. This NanoActivator has been installed at the University Hospital Munster as part of the preparations for the new ...
Tags: Glioblastoma study, NanoActivator, NanoTherm therapy, therapy
UK-based GlySure has completed patient enrollment for the multicenter CE Mark trial of its in-hospital continuous blood glucose monitoring (CBGM) system. The trial, led by principal investigator Dr Krishna Prasad, comprised 30 post ...
Tags: CE Mark Trial, Glysure
Colibri Heart Valve announced that patient enrollment has concluded in the first-in-human study of the Company's transcatheter aortic valve implantation (TAVI) system in the Dominican Republic trial site. Analysis of the data from ...
Tags: Colibri Heart Valve, Tavi System
Senesco Technologies reported the treatment of the first patient at the Company’s newly opened clinical-trial site at Seattle Cancer Care Alliance (SCCA). This patient is part of Senesco’s Phase 1b/2a clinical study of its ...
Tags: Senesco, Clinical Trial
Israel-based Cardiosonic announced it is currently enrolling patients in the TIVUS II clinical trial, designed to assess the safety, efficacy and performance of its TIVUS system using a next generation multidirectional catheter. TIVUS ...
Tags: Cardiosonic, Clinical Trial
Collegium Pharmaceutical, a specialty pharmaceutical company, has announced that a patent has been issued by the US Patent and Trademark Office (USPTO) covering its Oxycodone DETERx formulation. Additionally, an application has been ...
CardioFocus, developer of the HeartLight endoscopic ablation system (EAS) for the treatment of atrial fibrillation (AF), has concluded enrollment of its US pivotal trial evaluating the HeartLight system, for the treatment of symptomatic ...
US-based biopharmaceutical company MannKind has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking marketing authorization for its AFREZZA inhalation powder, indicated to improve glycemic control ...
Tags: Insulin Application, biopharmaceutical company MannKind
Vital Access, a provider of surgical and interventional technologies, has launched SAVE-2 post-market clinical follow-up study to investigate the benefits of VWING vascular needle guide for self-cannulation. The SAVE-2 study follows the ...